Mirza Muhammad Fahd Qadir

Pancreatic Islet Biologist and Computational Biologist.




Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes


Journal article


Taylor T Fuselier, Paula Mota de Sá, Fahd Qadir, Beibei Xu, C. Allard, Matt Meyers, J. Tiano, Bin Yang, V. Gelfanov, S. Lindsey, R. DiMarchi, F. Mauvais-Jarvis
Cell Reports Medicine, 2022

Semantic Scholar DOI
Cite

Cite

APA   Click to copy
Fuselier, T. T., de Sá, P. M., Qadir, F., Xu, B., Allard, C., Meyers, M., … Mauvais-Jarvis, F. (2022). Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes. Cell Reports Medicine.


Chicago/Turabian   Click to copy
Fuselier, Taylor T, Paula Mota de Sá, Fahd Qadir, Beibei Xu, C. Allard, Matt Meyers, J. Tiano, et al. “Efficacy of Glucagon-like Peptide-1 and Estrogen Dual Agonist in Pancreatic Islets Protection and Pre-Clinical Models of Insulin-Deficient Diabetes.” Cell Reports Medicine (2022).


MLA   Click to copy
Fuselier, Taylor T., et al. “Efficacy of Glucagon-like Peptide-1 and Estrogen Dual Agonist in Pancreatic Islets Protection and Pre-Clinical Models of Insulin-Deficient Diabetes.” Cell Reports Medicine, 2022.


BibTeX   Click to copy

@article{taylor2022a,
  title = {Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes},
  year = {2022},
  journal = {Cell Reports Medicine},
  author = {Fuselier, Taylor T and de Sá, Paula Mota and Qadir, Fahd and Xu, Beibei and Allard, C. and Meyers, Matt and Tiano, J. and Yang, Bin and Gelfanov, V. and Lindsey, S. and DiMarchi, R. and Mauvais-Jarvis, F.}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in